Cargando…
Identifying cisplatin-induced kidney damage in paediatric oncology patients
Cisplatin is one chemotherapeutic agent used to treat childhood cancer in numerous treatment protocols, including as a single agent. It is likely to remain in clinical use over the long term. However, cisplatin-related toxicities, including neurotoxicity and nephrotoxicity, are common, affecting tre...
Autores principales: | Barton, Chris D., Pizer, Barry, Jones, Caroline, Oni, Louise, Pirmohamed, Munir, Hawcutt, Daniel B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061670/ https://www.ncbi.nlm.nih.gov/pubmed/28821959 http://dx.doi.org/10.1007/s00467-017-3765-6 |
Ejemplares similares
-
The readability of parent information leaflets in paediatric studies
por: Nash, Elizabeth, et al.
Publicado: (2023) -
Pharmacogenetics of warfarin in a paediatric population: Time in therapeutic range, initial and stable dosing, and adverse effects
por: Hawcutt, Daniel B, et al.
Publicado: (2014) -
SWK-07. A MULTINATIONAL SURVEY OF PAEDIATRIC NEURO-ONCOLOGY SERVICES: A EUROPEAN RESEARCH NETWORK (ERN) PAEDCAN PROJECT
por: Cooper, Katherine, et al.
Publicado: (2020) -
Clinical coding of prospectively identified paediatric adverse drug reactions – a retrospective review of patient records
por: Bellis, Jennifer R, et al.
Publicado: (2014) -
Pediatric oncology services in Nepal
por: Sah, Kailash Prasad, et al.
Publicado: (2014)